Arrowhead Pharmaceuticals to Participate in Upcoming May 2026 Events
Arrowhead Pharmaceuticals announced its participation in several upcoming May 2026 conferences, including the BofA Securities Healthcare Conference and RBC Capital Markets Global Healthcare Conference. The company will present data on several assets, including late-breaker abstracts for PLOZASIRAN at EAS 2026 and new data for ARO-INHBE at EASL 2026.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.